Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates

Human Gene Therapy

Volumn 18, Issue 2, 2007, Pages 142-150

  Voutetakis, Antonis ^a   Zheng, Changyu ^a   Mineshiba, Fumi ^a   Cotrim, Ana P ^a   Goldsmith, Corinne M ^a   Schmidt, Michael ^a   Afione, Sandra ^a   Roescher, Nienke ^a   Metzger, Mark ^b   Eckhaus, Michael A ^c   Chiorini, John A ^a   Dunbar, Cynthia E ^b   Donahue, Robert E ^b   Baum, Bruce J ^a,d  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Gene Therapy and Therapeutics Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GENE PRODUCT; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EPO GENE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PAROTID GLAND; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RHESUS MONKEY; SALIVARY GLAND; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ANIMALS; BLOOD CELL COUNT; DEPENDOVIRUS; DNA, RECOMBINANT; ERYTHROPOIETIN; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MACACA MULATTA; MICE; MICE, INBRED BALB C; PAROTID GLAND; SALIVA; TISSUE DISTRIBUTION;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MACACA; MACACA MULATTA; MURINAE; MUS; PRIMATES; RODENTIA;

EID: 33947397152     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.154     Document Type: Article

References (42)

1. BACCAGLINI, L., HOQUE, A.T., WELLNER, R.B., GOLDSMITH, C.M., REDMAN, R.S., SANKAR, V., KINGMAN, A., BARNHART, K.M., WHEELER, C.J., and BAUM, B.J. (2001). Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo. J. Gene Med. 3, 82-90.
2. BAUM, B.J., BERKMAN, M.E., MARMARY, Y., GOLDSMITH, C.M., BACCAGLINI, L., WANG, S., WELLNER, R.B., HOQUE, A.T., ATKINSON, J.C., YAMAGISHI, H., KAGAMI, H., PARLOW, A.F., and CHAO, J. (1999). Polarized secretion of transgene products from salivary glands in vivo. Hum. Gene Ther. 10, 2789-2797.
3. BAUM, B.J., WELLNER, R.B., and ZHENG, C. (2002). Gene transfer to salivary glands. Int. Rev. Cytol. 213, 93-146.
4. BAUM, B.J., VOUTETAKIS, A., and WANG, J. (2004). Salivary glands: Novel target sites for gene therapeutics. Trends Mol. Med. 10, 585-590.
5. BOHL, D., SALVETTI, A., MOULLIER, P., and HEARD, J.M. (1998). Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adenoassociated vector. Blood 92, 1512-1517.
6. CASTLE, D., and CASTLE, A. (1998). Intracellular transport and secretion of salivary proteins. Crit. Rev. Oral Biol. Med. 9, 4-22.
7. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M. (1995). High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
8. CONRAD, C.K., ALLEN, S.S., AFIONE, S.A., REYNOLDS, T.C., BECK, S.E., FEEMAKI, M., BARRAZZA-ORTIZ, X., ADAMS, R., ASKIN, F.B., CARTER. B.J., GUGGINO, W.B., and FLOTTE, T.R. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3, 658-668.
9. CRYSTAL, R.G. (1995). The gene as a drug. Nat. Med. 1, 15-17.
10. DELPORTE, C., O'CONNELL, B.C., HE, X., LANCASTER, H.E., O'CONNELL, A.C., AGRE, P., and BAUM, B.J. (1997). Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. U.S.A. 94, 3268-3273.
11. EASTEAL S. (1991). The relative rate of DNA evolution in primates. Mol. Biol. Evol. 8, 115-127.
12. FAVRE, D., PROVOST, N., BLOUIN, V., BLANCHO, G., CHEREL, Y., SALVETTI, A., and MOULLIER, P. (2001). Immediate and long-term safety of recombinant adenoassociated virus injection into the nonhuman primate muscle. Mol. Ther. 4, 559-566.
13. GERDES, H.H., and GLOMBIK, M.M. (1999). Signal-mediated sorting to the regulated pathway of protein secretion. Ann. Anat. 181, 447-453.
14. GONIN, P., and GAILLARD, C. (2004). Gene transfer vector biodistribution: Pivotal safety studies in clinical gene therapy development. Gene Ther. 11, S98-S108.
15. HACKETT, N.R., REDMOND, D.E., SONDHI, D., GIANNARIS, E.L., VASSALLO, E., STRATTON, J., QIU, J., KAMINSKY, S.M., LESSER, M.L., FISCH, G.S., ROUSELLE, S.D., and CRYSTAL, R.G. (2005). Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates. Hum. Gene Ther. 16, 1484-1503.
16. HOQUE, A.T., BACCAGLINI, L., and BAUM, B.J. (2001). Hydroxychloroquine enhances the endocrine secretion of adenovirus-directed growth hormone from rat submandibular gland in vivo. Hum. Gene Ther. 12, 1333-1341.
17. ISENMAN, L., LIEBOW, C., and ROTHMAN, S. (1999). The endocrine secretion of mammalian digestive enzymes by exocrine glands. Am. J. Physiol. 276, E223-E232.
18. JACOBSON, S.G., ACLAND, G.M., AGUIRRE, G.D., ALEMAN, T.S., SCHWARTZ, S.B., CIDECIYAN, A.V., ZEISS, C.J., KOMAROMY, A.M., KAUSHAL, S., ROMAN, A.J., WINDSOR, E.A., SUMAROKA, A., PEARCE-KELLING, S.E., CONLON, T.J., CHIODO, V.A., BOYE, S.L., FLOTTE, T.R., MAGUIRE, A.M., BENNETT, J., and HAUSWIRTH, W.W. (2006). Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. Mol. Ther. 13, 1074-1084.
19. KALUDOV, N., HANDELMAN, B., and CHIORINI, J.A. (2002). Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography. Hum. Gene Ther. 13, 1235-1243.
20. KATANO, H., KOK, M.R., COTRIM, A.P., YAMANO, S., SCHMIDT, M., AFIONE, S., BAUM, B.J., and CHIORINI, J.A. (2006). Enhanced transduction of mouse salivary glands with AAV5-based vectors. Gene Ther. 13, 594-601.
21. KAY, M.A., and NAKAI, H. (2003). Looking into the safety of AAV vectors. Nature 424, 251.
22. KAY, M.A., GLORIOSO, J.C., and NALDINI, L. (2001). Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7, 33-40.
23. KELLY, R.B. (1985). Pathways of protein secretion in eukaryotes. Science 230, 25-32.
24. KHO, S.T., PETTIS, R.M., MHATRE, A.N., and LALWANI, A.K. (2000). Safety of adeno-associated virus as cochlear gene transfer vector: Analysis of distant spread beyond injected cochleae. Mol. Ther. 2, 368-373.
25. KOK, M.R., YAMANO, S., LODDE, B.M., WANG, J., COUWENHOVEN, R.I., YAKAR, S., VOUTETAKIS, A., LEROITH, D., SCHMIDT, M., AFIONE, S., PILLEMER, S.R., TSUTSUI, M.T., TAK, P.P., CHIORINI, J.A., and BAUM, B.J. (2003). Local adeno-associated virus-mediated interleukin 10 gene transfer has disease modifying effects in a murine model of Sjogren's syndrome. Hum. Gene Ther. 14, 1605-1618.
26. KOK, M.R., VOUTETAKIS, A., YAMANO, S., WANG, J., COTRIM, A., KATANO, H., BOSSIS, I., CHIORINI, J.A., TRAN, S.D., TAK, P.P., and BAUM, B.J. (2005). Immune responses following salivary gland administration of recombinant adenoassociated virus serotype 2 vectors. J. Gene Med. 7, 432-441.
27. LOH, Y.P., MALDONADO, A., ZHANG, C., TAM, W.H., and CAWLEY, N. (2002). Mechanisms of sorting pro-opiomelanocortin and pro-enkephalin to the regulated secretory pathway of neuroendocrine cells. Ann. N. Y. Acad. Sci. 971, 416-425.
28. MONAHAN, P.E., JOOSS, K., and SANDS, M.S. (2002). Safety of adeno-associated virus gene therapy vectors: A current evaluation. Expert Opin. Drug Saf. 1, 79-91.
29. NATHWANI, A.C., DAVIDOFF, A., HANAWA, H., ZHOU, J.F., VANIN, E.F., and NIENHUIS, A.W. (2001). Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 97, 1258-1265.
30. O'CONNELL, A.C., BACCAGLINI, L., FOX, P.C., O'CONNELL, B.C., KENSHALO, D., OWEISY, H., HOQUE, A.T., SUN, D., HERSCHER, L.L., BRADDON, V.R., DELPORTE, C., and BAUM, B.J. (1999). Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther. 6, 505-513.
31. PONNAZHAGAN, S., MUKHERJEE, P., YODER, M.C., WANG, X.S., ZHOU, S.Z., KAPLAN, J., WADSWORTH, S., and SRIVASTAVA, A. (1997). Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice. Gene 190, 203-210.
32. RIVERA, V.M., GAO, G.P., GRANT, R.L., SCHNELL, M.A., ZOLTICK, P.W., ROZAMUS, L.W., CLACKSON T., and WILSON, J.M. (2005). Long-term pharmacologically regulated expression of erythropoietin in primates following AAV mediated gene transfer. Blood 105, 1424-1430.
33. SHAN, Z., LI, J., ZHENG, C., LIU, X., FAN, Z., ZHANG, C., GOLDSMITH, C.M., WELLNER, R.B., BAUM, B.J., and WANG, S. (2005). Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. Mol. Ther. 11, 444-451.
34. SONG, S., SCOTT-JORGENSEN, M., WANG, J., POIRIER, A., CRAWFORD, J., CAMPBELL-THOMPSON, M., and FLOTTE, T.R. (2002). Intramuscular administration of recombinant adeno-associated virus 2 α-1 antitrypsin (rAAV-SERPINA1) vectors in a non-human primate model: safety and immunologic aspects. Mol. Ther. 6, 329-335.
35. TENENBAUM, L., LEHTONEN, E., and MONAHAN, P.E. (2003). Evaluation of risks related to the use of adeno-associated virus-based vectors. Curr. Gene Ther. 3, 545-565.
36. VOUTETAKIS, A., KOK, M.R., ZHENG, C., BOSSIS, I., WANG, J., COTRIM, A.P., MARRACINO, N., GOLDSMITH, C.M., CHIORINI, J.A., LOH, Y.P., NIEMAN, L.K., and BAUM, B.J. (2004a). Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc. Natl. Acad. Sci. U.S.A. 101, 3053-3058.
37. VOUTETAKIS, A., WANG, J., and BAUM, B.J. (2004b). Utilizing endocrine secretory pathways in salivary glands for systemic gene therapeutics. J. Cell. Physiol. 199, 1-7.
38. VOUTETAKIS, A., BOSSIS, I., KOK, M.R., ZHANG, W., WANG, J., COTRIM, A.P., ZHENG, C., CHIORINI, J.A., NIEMAN, L.K., and BAUM, B.J. (2005). Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J. Endocrinol. 185, 363-372.
39. WANG, J., VOUTETAKIS, A., MINESHIBA, F., ILLEI, G.G., DANG, H., YEH, C.K., and BAUM, B.J. (2006). Effect of serotype 5 adenoviral and serotype 2 adenoassociated viral vector-mediated gene transfer to salivary glands on the composition of saliva. Hum. Gene Ther. 17, 455-463.
40. WEN, D., BOISSEL, J.P., TRACY, T.E., GRUNINGER, R.H., MULCAHY, L.S., CZELUSNIAK, J., GOODMAN, M., and BUNN, H.F. (1993). Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood 82, 1507-1516.
41. YAMANO, S., HUANG, L.Y., DING, C., CHIORINI, J.A., GOLDSMITH, C.M., WELLNER, R.B., GOLDING, B., KOTIN, R.M., SCOTT, D.E., and BAUM, B.J. (2002). Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum. Gene Ther. 13, 287-298.
42. ZUFFEREY, R., and AEBISCHER, P. (2004). Salivary glands and gene therapy: The mouth waters. Gene Ther. 11, 1425-1426.